CEDRA Teams with Tucson-Based CellzDirect to Establish New Biotech Lab in Austin.Business Editors/Health/Medical Writers BIOWIRE2K AUSTIN, Texas--(BUSINESS WIRE)--Oct. 22, 2003 CEDRA CEDRA Controlled Simple Excitation for Dephasing Rotational Amplitudes Corporation, an Austin-based Contract Research Organization, is pleased to announce that it is teaming with CellzDirect Inc., a biotechnology company headquartered in Tucson, Ariz., to create a new biotechnology laboratory in Austin. The venture involves the sale of CEDRA's in vitro in vitro /in vi·tro/ (in ve´tro) [L.] within a glass; observable in a test tube; in an artificial environment. in vi·tro adj. In an artificial environment outside a living organism. drug metabolism Drug Metabolism/Interactions Definition Drug metabolism is the process by which the body breaks down and converts medication into active chemical substances. Precautions Drugs can interact with other drugs, foods, and beverages. division to CellzDirect; CEDRA's bioanalytical and clinical research business will remain intact and will continue to provide services to the healthcare industry. CellzDirect's primary goal is to become the leading provider of cell products and outsourced laboratory services for bio/pharma drug metabolism. Since September 2002, CellzDirect has partnered with CEDRA Corporation to offer hepatocytes and subcellular sub·cel·lu·lar adj. 1. Situated or occurring within a cell: subcellular organelles. 2. Smaller in size than ordinary cells: subcellular organisms. 3. fractions derived from human and animal livers to scientists who are conducting research in lead optimization, drug metabolism, drug-drug interactions, and toxicology. CellzDirect's senior management has had extensive experience with tissue procurement, life-science logistics, commercialization, and product development. Chief Executive Officer Scott Edelman Scott Edelman (born 1955) is an American science fiction, fantasy and horror writer and editor. As of 2007, he has been the editor of SCI FI Magazine (the official print magazine of The Sci Fi Channel) since 2002, as well the channel's online magazine has led several technology-based companies including GroupSystems, H.I.S, and Integral Systems, and has broad expertise in the integration of high-growth companies. Chief Business Officer Rick Williams previously was president of ICS/Lash, a consulting and service business. Williams also has broad expertise gained at AmerisourceBergen and Genentech where he led the marketing group. Williams' former colleagues from AmerisourceBergen's ASD ASD abbr. atrial septal defect ASD Atrial septal defect, see there division have partnered with CellzDirect by handling sales, customer service, and logistics to support the company's launch. Following the acquisition, CellzDirect will maintain its corporate headquarters in Tucson. The scientific team from CEDRA Corporation's in vitro drug metabolism division includes Dr. Riq Chacon, Dr. Chris Black, Dr. Charlie Fisher, Dr. Kishore Khan, Dr. Michael Cameron, and Ms. Karen Wright, and will soon move into CellzDirect's new cell-culture laboratory in Austin. CEDRA Corporation becomes a significant shareholder in CellzDirect. As a member of CellzDirect's Board of Directors and founder and CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. of CEDRA Corporation, Dr. David Garcia will be working with partners from Solstice solstice (sŏl`stĭs) [Lat.,=sun stands still], in astronomy, either of the two points on the ecliptic that lie midway between the equinoxes (separated from them by an angular distance of 90°). Capital, Valley Ventures, Technology Funding, and Village Ventures to guide CellzDirect in fulfilling its vision to collaborate with bio/pharma scientists to accelerate the discovery and development of breakthrough drugs while preventing patients from being exposed to potentially dangerous side effects Side effects Effects of a proposed project on other parts of the firm. . In conjunction with the acquisition, CellzDirect closed a $2.1M round of financing and all current institutional investors -- Valley Ventures, Solstice Capital, Technology Funding and Village Ventures -- participated in this corporate expansion. CellzDirect has raised $6.5 million since its inception in April of 2000. According to CEO Scott Edelman, "This is our first acquisition and it will enable us immediately to provide our scientific customers with a broader array of cell products and outsourced-research services. We are committed to maintaining the same high standards of quality assurance That CEDRA has set while building this successful drug-metabolism business." Dr. Garcia states that he is excited about this new business venture and will make CEDRA's laboratory and quality-assurance resources available to CellzDirect during the next year to facilitate a smooth transition. Both CEDRA Corporation and CellzDirect remain committed to providing the highest quality cell products, in vitro metabolism services, and bioanalytical services to the healthcare community. In addition to analytical chemistry services, CEDRA Corporation also offers toxicology/pharmacology, metabolic, synthetic chemistry, pharmacokinetic/statistical and clinical research services. CEDRA Corporation (http://www.cedracorp.com) and its wholly owned subsidiary Wholly Owned Subsidiary A subsidiary whose parent company owns 100% of its common stock. Notes: In other words, the parent company owns the company outright and there are no minority owners. CEDRA Clinical Research, LLC (Logical Link Control) See "LANs" under data link protocol. LLC - Logical Link Control , have been providers of excellence in biotechnical services for the pharmaceutical industry and the Federal government since 1990. |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion